InsiderTrades

Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001415889-23-002515 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-02-14 2023-02-10+ HALO LaBarre Michael J. SVP, Chief TECHNICAL Off F - Tax $48.92 -5,676 148.3K -4% -$277.7K
DM 2023-02-14 2023-02-10+ HALO LaBarre Michael J. SVP, Chief TECHNICAL Off M - OptEx $0.00 +16.0K 151.3K +12% $0
DM 2023-02-14 2023-02-10+ HALO LaBarre Michael J. SVP, Chief TECHNICAL Off M - OptEx $0.00 -16.0K 8,133 -66% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-12 F D 2,725 $48.92 153,477 D — — (F2) The reported disposition of 2,725 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
2 Common Common Stock 2023-02-12 M A 7,883 $0.00 156,202 D — —
3 Common Common Stock 2023-02-10 M A 8,133 $0.00 151,270 D — —
4 Common Common Stock 2023-02-10 F D 2,951 $48.92 148,319 D — — (F1) The reported disposition of 2,951 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
5 Derivative Restricted Stock Unit 2023-02-12 M D 7,883 $0.00 0 D $0.00 · — to — 7,883 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
6 Derivative Restricted Stock Units 2023-02-10 M D 8,133 $0.00 8,133 D $0.00 · — to — 8,133 Common Stock (F3) This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.